-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Ayala Pharmaceuticals, Inc. annual/quarterly Earnings Per Share, Diluted history and growth rate from 2010 to 2023.
- Ayala Pharmaceuticals, Inc. Earnings Per Share, Diluted for the quarter ending September 30, 2023 was -1.53 USD/shares, a 56.4% increase year-over-year.
- Ayala Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2023 was -7.99 USD/shares, a 39.1% increase from 2022.
- Ayala Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2022 was -13.1 USD/shares.
- Ayala Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2011 was -0.04 USD/shares, a 42.9% increase from 2010.
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)